Mesoblast (MESO) Cash & Equivalents (2015 - 2026)
Mesoblast (MESO) posted Cash & Equivalents of $102.91 million for the quarter ended Jun 30, 2026, down 36.3% from $161.55 million a year earlier.
Powered by 
Analysis
Mesoblast (MESO) Cash & Equivalents (2015 - 2026) Analysis & Trends
Since the quarter ended Jun 30, 2015, Mesoblast has reported Cash & Equivalents for 39 quarters.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -5.5% (years ended Jun 2021 to Jun 2026).
- In prior years, Mesoblast's Cash & Equivalents was $161.55 million in the year ended Jun 30, 2025 (+156.6%), $62.96 million in the year ended Jun 30, 2024 (-11.7%), $71.32 million in the year ended Jun 30, 2023 (+18.0%) and $60.45 million in the year ended Jun 30, 2022 (-55.8%).
- The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Cash & Equivalents since the quarter ended Dec 31, 2024.
- On a year-over-year basis, Cash & Equivalents increased in two of the last four quarters, with growth averaging 77.8%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was the quarter ended Dec 31, 2025, with growth of 241.8%; the weakest was the quarter ended Jun 30, 2022, with a decline of 55.8%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Mesoblast | 1.81 Bn | 1.38 Bn | - | 102.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 102.91 Mn |
| Dec 31, 2025 | 130.00 Mn |
| Jun 30, 2025 | 161.55 Mn |
| Dec 31, 2024 | 38.03 Mn |
| Jun 30, 2024 | 62.96 Mn |
| Dec 31, 2023 | 77.55 Mn |
| Jun 30, 2023 | 71.32 Mn |
| Mar 31, 2023 | 48.80 Mn |
| Dec 31, 2022 | 67.62 Mn |
| Sep 30, 2022 | 85.50 Mn |
| Jun 30, 2022 | 60.45 Mn |
| Mar 31, 2022 | 76.76 Mn |
| Dec 31, 2021 | 94.85 Mn |
| Sep 30, 2021 | 115.96 Mn |
| Jun 30, 2021 | 136.88 Mn |
| Mar 31, 2021 | 158.26 Mn |
| Dec 31, 2020 | 77.53 Mn |
| Sep 30, 2020 | 108.12 Mn |
| Jun 30, 2020 | 129.33 Mn |
| Mar 31, 2020 | 60.08 Mn |
API Access
Mesoblast Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MESO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "MESO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MESO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();